Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Aesthetic Plastic Surgery
Published in: Aesthetic Plastic Surgery 5/2021

01-10-2021 | Abdominoplasty | Letter to the Editor

Botulinum Toxin Type A Injection for Mammoplasty and Abdominoplasty Scar Management: A Split-Scar Double-Blinded Randomized Controlled Study

Authors: Danying Wang, Bo Chen

Published in: Aesthetic Plastic Surgery | Issue 5/2021

Login to get access

Excerpt

Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266. …
Literature
1.
Huang RL, Ho CK, Tremp M, Xie Y, Li Q, Zan T (2019) Early postoperative application of botulinum toxin type A prevents hypertrophic scarring after epicanthoplasty: a split-face, double-blind, randomized trial. Plast Reconstr Surg 144(4):835–844CrossRef
2.
Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87(10):1044–1049CrossRef
3.
Lee HJ, Jang YJ (2018) Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids. Int J Mol Sci 19(3):711CrossRef
4.
Abedini R, Mehdizade Rayeni N, Haddady Abianeh S, Rahmati J, Teymourpour A, Nasimi M (2020) Botulinum toxin type A injection for mammoplasty and abdominoplasty scar management: a split-scar double-blinded randomized controlled study. Aesthet Plast Surg 44(6):2270–2276CrossRef
Metadata
Title
Botulinum Toxin Type A Injection for Mammoplasty and Abdominoplasty Scar Management: A Split-Scar Double-Blinded Randomized Controlled Study
Authors
Danying Wang
Bo Chen
Publication date
01-10-2021
Publisher
Springer US
Published in
Aesthetic Plastic Surgery / Issue 5/2021
Print ISSN: 0364-216X
Electronic ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-021-02218-2

Other articles of this Issue 5/2021

Aesthetic Plastic Surgery 5/2021 Go to the issue

Editor’s Invited Commentary

Invited Discussion on: Lipo-Bodylift Reconstruction Following Massive Weight Loss—Our Experience with 100 Consecutive Cases

Editor’s Invited Commentary

Invited Discussion on: Percutaneous Intradermal Purse-String Closure for Correction of Male Tuberous Nipple–Areola Complex Deformity

Original Article

The Effect of Arm Position on Breast Volume Measurement Using Three-dimensional Imaging

Editor’s Invited Commentary

Invited Discussion on: A Prospective Study Determining Patient Satisfaction with Combined Cryolipolysis and Shockwave Therapy Treatment for Non-Invasive Body Contouring

Review

Tissue Fillers for the Nasolabial Fold Area: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Editor’s Invited Commentary

Invited Discussion on: Is Orbicularis Oculi Muscle Resection Necessary in Blepharoplasty? A Systemic Review